 |
Counterfeit medicines are on the rise and are becoming a real threat to the pharmaceutical industry. As a result, the EU Falsified Medicines Directive and other legal provisions have defined a strong legal framework for the manufacture and global distribution of medicines.
Reliable traceability and compliance with these regulations are essential for pharmaceutical manufacturers, who must produce safe products and protect the legitimate supply chain from counterfeit medicines.
Most pharmaceutical companies, in collaboration with reliable partners, have already begun to consider implementing a serialization strategy and defining their requirements for serialization solutions for their production line.
This educational white paper provides pharmaceutical manufacturers with essential information to help them implement an effective serialization program.
